111 Current Ratio 2018-2024 | YI

111 current ratio from 2018 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
111 Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $0.37B $0.34B 1.07
2024-03-31 $0.39B $0.36B 1.08
2023-12-31 $0.41B $0.39B 1.07
2023-09-30 $0.44B $0.41B 1.07
2023-06-30 $0.39B $0.32B 1.22
2023-03-31 $0.44B $0.36B 1.21
2022-12-31 $0.47B $0.40B 1.19
2022-09-30 $0.39B $0.32B 1.24
2022-06-30 $0.42B $0.34B 1.25
2022-03-31 $0.42B $0.33B 1.29
2021-12-31 $0.44B $0.33B 1.32
2021-09-30 $0.43B $0.32B 1.37
2021-06-30 $0.46B $0.32B 1.43
2021-03-31 $0.43B $0.27B 1.62
2020-12-31 $0.44B $0.25B 1.76
2020-09-30 $0.38B $0.26B 1.47
2020-06-30 $0.25B $0.18B 1.42
2020-03-31 $0.21B $0.13B 1.65
2019-12-31 $0.21B $0.11B 1.92
2019-09-30 $0.22B $0.09B 2.32
2019-06-30 $0.24B $0.10B 2.51
2019-03-31 $0.23B $0.07B 3.28
2018-09-30 $0.24B $0.05B 4.61
2018-06-30 $0.16B $0.05B 3.04
2017-12-31 $0.11B $0.03B 3.63
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.053B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00